Cargando…

Epidermal growth factor receptor gene copy number in 101 advanced colorectal cancer patients treated with chemotherapy plus cetuximab

BACKGROUND: Responsiveness to Cetuximab alone can be mediated by an increase of Epidermal Growth factor Receptor (EGFR) Gene Copy Number (GCN). Aim of this study was to assess the role of EGFR-GCN in advanced colorectal cancer (CRC) patients receiving chemotherapy plus Cetuximab. METHODS: One hundre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campanella, Carla, Mottolese, Marcella, Cianciulli, Anna, Torsello, Angela, Merola, Roberta, Sperduti, Isabella, Melucci, Elisa, Conti, Salvatore, Diodoro, Maria Grazia, Zeuli, Massimo, Paoletti, Giancarlo, Cognetti, Francesco, Garufi, Carlo
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867799/ https://www.ncbi.nlm.nih.gov/pubmed/20398370 http://dx.doi.org/10.1186/1479-5876-8-36

Ejemplares similares

Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial
por: Garufi, C, et al.
Publicado: (2010)

Gender effects of single nucleotide polymorphisms and miRNAs targeting clock-genes in metastatic colorectal cancer patients (mCRC)
por: Garufi, Carlo, et al.
Publicado: (2016)

Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity after radioembolization with yttrium-90 resin microspheres
por: Melucci, Elisa, et al.
Publicado: (2013)

High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis
por: Benevolo, Maria, et al.
Publicado: (2011)

Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers
por: Bon, Giulia, et al.
Publicado: (2016)

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study
por: Novelli, Flavia, et al.
Publicado: (2008)

BRAF status modulates Interelukin-8 expression through a CHOP-dependent mechanism in colorectal cancer
por: Conciatori, Fabiana, et al.
Publicado: (2020)

Induction of ErbB-3 Expression by α6β4 Integrin Contributes to Tamoxifen Resistance in ERβ1-Negative Breast Carcinomas
por: Folgiero, Valentina, et al.
Publicado: (2008)

Early-onset colorectal cancer patients without family history are “at very low risk” for lynch syndrome
por: Stigliano, Vittoria, et al.
Publicado: (2014)

Gene Copy Number Variation in Male Breast Cancer by aCGH
por: Tommasi, Stefania, et al.
Publicado: (2010)

Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer
por: Braig, Friederike, et al.
Publicado: (2015)

Isolation and characterization of novel mutations in the pSC101 origin that increase copy number
por: Thompson, Mitchell G., et al.
Publicado: (2018)

Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients
por: Scartozzi, M, et al.
Publicado: (2011)

Phase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptor
por: Dudek, A Z, et al.
Publicado: (2009)

Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers
por: Caruso, Anita, et al.
Publicado: (2009)

Review of cetuximab in the treatment of squamous cell carcinoma of the head and neck
por: Merlano, Marco, et al.
Publicado: (2007)

Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer
por: Bria, Emilio, et al.
Publicado: (2014)

Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma
por: KURAI, JUN, et al.
Publicado: (2012)

Chimeric Monoclonal Antibody Cetuximab Targeting Epidermal Growth Factor-Receptor in Advanced Non-Melanoma Skin Cancer
por: Wollina, Uwe, et al.
Publicado: (2017)

Enhanced Antitumor Effects of Epidermal Growth Factor Receptor Targetable Cetuximab-Conjugated Polymeric Micelles for Photodynamic Therapy
por: Chang, Ming-Hsiang, et al.
Publicado: (2018)

Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study
por: Di Lauro, Luigi, et al.
Publicado: (2015)

Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters
por: Caetano-Pinto, Pedro, et al.
Publicado: (2017)

KRAS Gene Copy Number as a Negative Predictive Biomarker for the Treatment of Metastatic Rectal Cancer With Cetuximab: A Case Report
por: Xiong, Qunli, et al.
Publicado: (2022)

Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
por: Melucci, Elisa, et al.
Publicado: (2018)

Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis
por: Scartozzi, Mario, et al.
Publicado: (2009)

Epidermal Growth Factor Receptor Mutation Status and Rad51 Determine the Response of Glioblastoma to Multimodality Therapy with Cetuximab, Temozolomide, and Radiation
por: Wachsberger, Phyllis Rachelle, et al.
Publicado: (2013)

(111)In-cetuximab as a diagnostic agent by accessible epidermal growth factor (EGF) receptor targeting in human metastatic colorectal carcinoma
por: Shih, Ying-Hsia, et al.
Publicado: (2015)

Serological response to COVID-19 vaccination in patients with cancer older than 80 years
por: Iacono, Daniela, et al.
Publicado: (2021)

hMENA splicing program impacts the clinical outcome of early stage lung cancer patients. How and why?
por: Visca, Paolo, et al.
Publicado: (2014)

Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis
por: Di Lauro, Luigi, et al.
Publicado: (2015)

Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma
por: Fertig, Elana J, et al.
Publicado: (2012)

Expression of Epidermal Growth Factor Receptor Detected by Cetuximab Indicates Its Efficacy to Inhibit In Vitro and In Vivo Proliferation of Colorectal Cancer Cells
por: Shigeta, Kohei, et al.
Publicado: (2013)

Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer
por: Simone, Giovanni, et al.
Publicado: (2010)

Cetuximab in the management of colorectal cancer
por: Lenz, Heinz-Josef
Publicado: (2007)

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2020)

Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients
por: Ferraresi, Virginia, et al.
Publicado: (2010)

EGFR Gene Copy Number as a Prognostic Marker in Colorectal Cancer Patients Treated with Cetuximab or Panitumumab: A Systematic Review and Meta Analysis
por: Jiang, Zheng, et al.
Publicado: (2013)

Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
por: Mekenkamp, Leonie JM, et al.
Publicado: (2012)

Measurements of the beta-decay energy of $^{101}$Rb, $^{101,102}$Sr and $^{101,102}$Y
por: Balog, K, et al.
Publicado: (1990)

Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients
por: Fabi, Alessandra, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t6jlsummll2pli7ei7grbb98nq